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ABSTRACT: Snake venoms are mixtures of biologically-active proteins and peptides, and several 11 
studies have described the characteristics of some of these toxins. However, complete proteomic profiling 12 
of the venoms of many snake species has not yet been done. The Indian cobra (Naja naja) and common 13 
krait (Bungarus caeruleus) are elapid snake species that are among the ‘Big Four’ responsible for the 14 
majority of human snake envenomation cases in India. As understanding the composition and complexity 15 
of venoms is necessary for successful treatment of envenomation in humans, we utilized three different 16 
proteomic profiling approaches to characterize these venoms: i) one-dimensional SDS-PAGE coupled 17 
with in-gel tryptic digestion and electrospray tandem mass spectrometry (ESI-LC-MS/MS) of individual 18 
protein bands; ii) in-solution tryptic digestion of crude venoms coupled with ESI-LC-MS/MS; and iii) 19 
separation by gel-filtration chromatography coupled with tryptic digestion and ESI-LC-MS/MS of 20 
separated fractions. From the generated data, 81 and 46 different proteins were identified from N. naja 21 
and B. caeruleus venoms, respectively, belonging to fifteen different protein families. Venoms from both 22 
species were found to contain a variety of phospholipases A2 and three-finger toxins, whereas relatively 23 
higher numbers of snake venom metalloproteinases were found in N. naja compared to B. caeruleus 24 
venom. The analyses also identified less represented venom proteins including L-amino acid oxidases, 25 
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cysteine-rich secretory proteins, 5’-nucleotidases and venom nerve growth factors. Further, Kunitz-type 26 
serine protease inhibitors, cobra venom factors, phosphodiesterases, vespryns and aminopeptidases were 27 
identified in the N. naja venom, while acetylcholinesterases and hyaluronidases were found in the B. 28 
caeruleus venom. We further analysed protein coverage (Lys/Arg rich and poor regions as well as 29 
potential glycosylation sites) using in-house software.  These studies expand our understanding of the 30 
proteomes of the venoms of these two medically-important species. 31 
Keywords: toxins, venomics, venom variation, ESI-LC-MS/MS, tryptic digestion, toxin profile. 32 
1. Introduction 33 
 Snake bite is a serious medical problem in tropical and sub-tropical regions, including India. The 34 
annual number of human deaths due to snake bite in India is conservatively estimated at 35,000 to 50,000, 35 
and the majority of bites are inflicted by the Indian or spectacled cobra (Naja naja), common krait 36 
(Bungarus caeruleus), saw-scaled viper (Echis carinatus) and Russell’s viper (Daboia russelii) (Warrell, 37 
1999; Sharma et al., 2015), the so-called “Big Four” venomous snakes of India (although there is debate 38 
as to whether a fifth species, the hump-nosed viper [Hypnale hypnale] should be included as a “big fifth” 39 
species; Joseph et al. 2007; Simpson and Norris 2007). Such a notably high number of snake bite related 40 
deaths are due to the close interaction between human and snake populations as well as the high toxicity 41 
of these snake venoms. Snake venoms are complex mixtures of proteins, peptides and other molecules 42 
that are produced by specialized venom glands and used for prey acquisition as well as defense against 43 
potential predators (Stocker, 1990). The diversity of bioactive molecules in venoms has been used to 44 
design pharmacologically active substances as potential drug leads and to develop precise research tools 45 
for better understanding of mammalian physiological pathways (Stocker, 1990; Koh and Kini, 2012). 46 
         In this study, we have chosen to evaluate the composition of the venoms of two elapid snakes 47 
belonging to the “Big Four”: N. naja and B. caeruleus. Naja naja is native to the Indian subcontinent and 48 
found throughout Pakistan, Sri Lanka, Bangladesh and Southern Nepal. Bungarus caeruleus is found 49 
from the West Bengal plains of India to the Sindh province of Pakistan; occurs through South India and 50 
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Sri Lanka; and is recorded from Afghanistan, Bangladesh, and Nepal. Although neurotoxicity, which 51 
leads to acute neuromuscular paralysis (potentially causing morbidity and mortality), is a common effect 52 
of envenomation by these elapid snakes (Seneviratne and Dissanayake, 2002; Bawaskar and Bawaskar, 53 
2004; Ranawaka et al., 2013), other toxins present in these venoms may also determine the overall effect. 54 
Analysis of venom composition along with characterization of individual new toxins is needed to 55 
elucidate mechanisms of venom toxicity (Yang, 1996) in an attempt to correlate the two (a field now 56 
termed “toxicovenomics” (Calvete 2015; Lauridsen et al. 2016,2017). Venom composition exhibits 57 
intraspecific (seasonal, geographical and ontogenetic) variations in numbers and types of toxins making 58 
species-level characterization an interesting challenge (e.g. Chippaux et al. 1991; Daltry et al. 1996A,B; 59 
Alape-Girón et al. 2008; Calvete et al. 2009). Previous studies have demonstrated regional differences in 60 
the compositional, biochemical and pharmacological properties of N. naja venoms within India, and these 61 
differences correlate with the severity of pathogenesis (Mukherjee and Maity, 1998; Shashidharamurthy 62 
et al., 2002; Shashidharamurthy et al., 2010; Saikumari et al., 2015). 63 
 Relatively few proteomics studies of the venoms of either of these two dangerous elapids have 64 
been conducted. One previous study reported 26 proteins (with two or more associated peptide hits) from 65 
seven toxin families in the venom of a N. naja from Pakistan utilizing a combination of 2D gel 66 
electrophoresis and tryptic digest of crude venom followed by LC-MS/MS (Ali et al., 2013). 67 
Sintiprungrat et al. (2016) compared the venomics of N. naja from western India (pool of venom from 68 
Rajasthan and Gujarat) and Sri Lanka, and six major venom protein families were reported in venoms 69 
from both areas.  These were the three-finger toxin (3FTx), phospholipase A2 (PLA2), cysteine-rich 70 
secretory protein (CRISP), snake venom metalloproteinase (SVMP), venom growth factor, and protease 71 
inhibitor protein families. Proteomic analysis of N. naja from eastern India revealed 43 proteins belonging 72 
to 15 venom protein families (Dutta et al., 2017; minimum one peptide used to call protein). Further, 73 
earlier reports on the characterization of thermostable peptides from N. naja venom (Vietnam) revealed 74 
32 polypeptides and proteins belonging to the 3FTx, PLA2, cobra venom factor (CVF), L-amino acid 75 
4 
 
oxidase (LAAO), CRISP, and SVMP protein families (Binh et al., 2010). A number of PLA2s (Bhat et al., 76 
1991; Bhat and Gowda, 1991; Rudrammaji and Gowda, 1998; Sudarshan and Dhananjaya, 2016), SVMPs 77 
(Jagadeesha et al., 2002), and other venom toxin components (Karlsson et al., 1971; Müller-Eberhard and 78 
Fjellström, 1971; Shafqat et al., 1990; Girish et al., 2004) have also been isolated and characterized from 79 
N. naja venom. During the revision of this manuscript, venomic analysis of B. caeruleus venom (pooled 80 
from Southeastern India and unspecified locales within India) was reported, with the observation that 81 
68.2% of total proteins were PLA2s, including β-bungarotoxins (Oh et al., 2017). Moreover, only a few 82 
protein toxins have been purified and characterized from B. caeruleus venom (Bon and Changeux, 1975; 83 
Moody and Raftery, 1978; Sharma et al., 1999; Singh et al., 2001, 2005; Mirajkar et al., 2005; More et 84 
al., 2010).  85 
  Improvement of proteomic techniques, including the development of high resolution mass 86 
spectrometry and the deposition of protein sequences in accessible databases, has allowed for more 87 
thorough snake venom profiling in shorter time frames (Calvete et al., 2007, 2009). Recent proteomic 88 
research has in turn spurred development of powerful methods for toxin characterization and 89 
immunological profiling of snake venoms (Pla et al., 2012; Gutiérrez et al., 2013). Hence, the information 90 
generated by such studies will potentially help in the production of more effective antivenoms and in the 91 
discovery of protein leads for the development of therapeutics (Vetter et al., 2011). In the present study 92 
we utilized three different proteomic strategies to characterize the venoms of two medically-important 93 
elapid snake species. The first strategy was one dimensional SDS-PAGE, which was used to separate the 94 
constituent proteins after which tryptic digestion of bands and electrospray tandem mass spectrometry 95 
(ESI-LC-MS/MS) of resulting peptides was used to identify them. The second strategy was tryptic 96 
digestion of crude venom followed by ESI-LC-MS/MS. The third strategy was gel filtration (GF) 97 
followed by ESI-LC-MS/MS of the separated fractions. By combining these three complimentary 98 
techniques, we have generated more comprehensive proteomic profiles of the venoms of N. naja and B. 99 
caeruleus than have been previously reported. 100 
5 
 
2. Materials and methods 101 
2.1. Venoms  102 
Lyophilized crude N. naja and B. caeruleus venoms were procured from the Irula Snake 103 
Catcher’s Society, Tamil Nadu, India. The snakes were from within Tamil Nadu state, and venoms were 104 
pooled from a number of individuals. The venoms were reconstituted in water prior to analysis unless 105 
stated otherwise.  106 
2.2. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of venoms 107 
SDS-PAGE was performed in 12% polyacrylamide according to the method of Laemmli (1970). 108 
Crude venom samples (20 µg), each treated with non-reducing buffer were loaded in separate wells. The 109 
gels were stained with Coomassie blue and then destained by using 5% acetic acid in water. PageRuler™ 110 
prestained protein marker (Thermo Scientific, Waltham, MA, USA) was used for estimating molecular 111 
weight.  112 
2.3. In-gel tryptic digestion   113 
Each band from SDS-PAGE gels was cut and destained using 200 µl MeOH: 50 mM NH4HCO3 114 
(1:1 v/v), and later dehydration was done using 200 µl ACN: 50 mM NH4HCO3 (1:1 v/v). Next, 200 µl of 115 
100% ACN was added. The protein in the gel bands was reduced using 100 µl of 25 mM DTT in 50 mM 116 
NH4HCO3 for 20 min followed by alkylation in the dark at room temperature with 100 µl of 55 mM 117 
iodoacetamide (Sigma, St. Louis, MO, USA) in 50 mM NH4HCO3 for 15 min. Samples were then washed 118 
with 200 μl of 50 mM NH4HCO3 in 50% ACN for 15 min and dehydrated with 200 μl of 100% ACN at 119 
room temperature for 15 min. The gels were digested using 20 μl of 12 ng/µl trypsin (Trypsin Gold, 120 
Promega, Madison, WI, USA). Next 30 µl of 0.01% ProteaseMAX in 50 mM NH4HCO3 was added, and 121 
the sample was gently mixed and incubated at 37˚C for 3 h. After incubation, 0.5 µl TFA was added to 122 
inactivate trypsin. The samples were centrifuged at 12,000 rpm and supernatants were loaded onto an 123 
HPLC-MS/MS system.  124 
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2.4. Gel filtration chromatography of crude N. naja and B.caeruleus venom  125 
Crude venoms (100 mg) were dissolved in 2.5 ml of 50 mM Tris-HCl (pH 7.4) and filtered 126 
through 0.2 mm nylon syringe filters. The clear venom filtrates (1 ml) were loaded onto a HiLoad 16/60 127 
Superdex 200 pg gel filtration column (GE Healthcare, Uppsala, Sweden) pre-equilibrated with 50 mM 128 
Tris-HCl (pH 7.4). Proteins were eluted at a flow rate of 1 ml/min with the same buffer using an Äkta 129 
Purifier HPLC system (GE Healthcare), and the elution was monitored at 215 and 280 nm.  130 
2.5. In-solution tryptic digestion  131 
Individual freeze-dried crude venom samples and gel-filtration fractions were reconstituted in 132 
deionized water (4 µg/µl).  Each sample (50 µl) was mixed with 41.5 µl of 50 mM NH4HCO3 buffer, 1.0 133 
µl DTT (for reduction), and 2.0 µl of 1% ProteaseMAX detergent (in 50 mM NH4HCO3) and incubated at 134 
56°C for 20 min.  Each sample was alkylated by adding 2.7 µl of 0.55 M iodoacetamide, and the mixture 135 
was incubated at room temperature (22-24°C) in the dark for 15 min.  Trypsin (1.8 µg/µl in 50 mM acetic 136 
acid) was then added, and the samples were incubated at 37°C for 3 h.  Next, 0.5 μl TFA was added and 137 
the mixture incubated at room temperature for 10 min.  Samples were centrifuged at 10,000 rpm for 10 138 
min, and supernatants were analyzed by HPLC-MS/MS.  139 
2.6. Electrospray tandem mass spectrometry (ESI-LC-MS/MS) 140 
The tryptic digests of individual samples obtained by in-gel or in-solution digestion (described 141 
above) were loaded onto an Accela LCQ Fleet ion trap mass spectrometer. Each 80 μl sample was 142 
injected onto a Hypersil Gold C18 column (50 x 2.1 mm, Thermo Scientific, Waltham, MA, USA) pre-143 
equilibrated with 0.1% formic acid (buffer A). Elution was carried out at a flow rate 200 µl/min with a 144 
linear gradient of 100% ACN in 0.1% formic acid (buffer B). The gradient was set from 0 to 40% buffer 145 
B over 38 min and then from 40 to 80% over 18 min. The eluent from the LC column was directly fed to 146 
the mass spectrometer, and the system was set to positive ionization mode. Spectra were obtained with a 147 
scan range of 500 to 2000 m/z.  148 
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2.7. Protein and peptide identification 149 
MS/MS spectra were analyzed using SEQUEST and Proteome Discoverer 3.1 software with a 150 
false discovery rate of 0.01. The peptide fragments were assigned to protein families based on their 151 
similarity to sequences in the Lepidosauria subset of the National Centre for Biotechnology Information 152 
(NCBI) database. If at least two peptides were detected (with at least one being unique), protein species 153 
were considered to be present in the sample. Only proteins with a SEQUEST score of 2.0 or higher were 154 
utilized for analysis.  155 
2.8. Visualization of SEQUEST output  156 
The portions of the protein sequences covered by peptides detected via tandem mass spectrometry 157 
were visualized using an in-house Perl script. The program generates figures showing the peptide 158 
coverage, potential glycosylation sites and lysine (K) or arginine (R) rich and poor regions. As trypsin 159 
lyses proteins directly after K or R residues, the regions that are too high or too low in presence of these 160 
residues are either too small or too large (respectively) to be detected by MS based on the range 161 
parameters set. K/R-rich and K/R-poor regions were defined as protein segments containing more than 162 
two K/R within 3 to 5 residues or lacking K/R within 20 to 25 residues, respectively.  The tryptic peptides 163 
with 5 to 20 residues were considered as potentially detectable with the standard experimental parameters. 164 
Although we did not specifically check for glycosylated peptides, their presence can cause failure in 165 
peptide detection due to uncertainty pertaining to the mass of sugar moieties, they may lead to peptides 166 
containing them being undetected. For this reason, we mapped potential glycosylation sites (predicted by 167 
the presence of NXT/NXS, where X is any residue except a proline). 168 
3. Results and Discussion 169 
3.1. Proteomics of SDS-PAGE gel bands 170 
The abundance of high and low molecular weight proteins in both crude venoms was shown by 171 
SDS-PAGE (Fig.1). Visually, the banding patterns in the two venoms are distinct, with N. naja venom 172 
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appearing to have a greater number of large molecular weight proteins than B. caeruleus venom.   Based 173 
on published molecular weights, the prominent bands indicate the potential proteins from various toxin 174 
families including 3FTx, PLA2, CRISP, LAAO, and SVMP, among others, in both the venoms. The 175 
individual gel bands were sliced, pooled into four fractions (Fig. 1) and further subjected to in-gel trypsin 176 
digestion and HPLC-MS/MS. From the SDS-PAGE bands of N. naja venom, 25 total proteins belonging 177 
to ten toxin families were identified (Table S1). Likewise, from the B. caeruleus SDS-PAGE bands, we 178 
identified twenty three proteins from six different toxin families (Table S2). 179 
3.2. Proteomics of venom by direct tryptic digestion   180 
Crude venoms of N. naja and B. caeruleus were subjected to tryptic digestion and further analysis 181 
using HPLC-MS/MS. Forty different proteins from 13 toxin families were identified from the N. naja 182 
venom (Table S1). Similarly, from the B. caeruleus crude venom, we identified 43 different proteins from 183 
eight toxin families (Table S2).  184 
3.3. Proteomics of gel-filtration fractions 185 
 The N. naja crude venom subjected to gel filtration chromatography yielded nine distinct protein 186 
peaks (Fig. 2). Within these peaks, 75 total proteins belonging to 14 toxin families were detected. In the 187 
B. caeruleus crude venom, seven distinct peaks were seen (Fig. 3) and within these peaks 34 total proteins 188 
from eight toxin families were observed. Identities of individual proteins are listed in Tables S1 and S2. 189 
Interestingly, gel filtration of N. naja venom yielded 36 proteins not identified using other techniques, but 190 
gel filtration of B. caeruleus venom yielded no unique peptides (Fig. 4).  191 
3.4. Analyses of toxin families and isoforms 192 
 The complete analysis of the peptides obtained using combined approaches provided a 193 
comprehensive overview of the different protein families and species present in both N. naja (Fig 5) and 194 
B. caeruleus venoms (Fig. 6).  The most widely used proteomic profiling workflow (Lomonte and 195 
Calvete, 2017) has some difficulty in eluting larger proteins of low abundance from C18 HPLC columns. 196 
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In this study, we have used complementary approaches so as to avoid such issues and to generate a more 197 
complete proteomic profile. The approaches using in-gel or crude venom tryptic digestion coupled with 198 
ESI-LC-MS/MS detected a similar number of proteins in both N. naja and B. caeruleus venoms. This 199 
might be due to the abundance of low to medium sized (in terms of molecular weight) proteins in both of 200 
the venoms. The presence of a larger number of high molecular weight proteins in N. naja crude venom 201 
compared to B. caeruleus, as observed in SDS-PAGE profiles, has resulted in 36 proteins being identified 202 
in N. naja venom using the third approach (in-solution tryptic digestion of gel-filtration fractions and ESI-203 
LC-MS/MS) compared to none in B. caeruleus venom.   The differences and similarities in protein 204 
profiles between the two species on examination of the proteomic results are discussed in detail. 205 
3.4.1. PLA2 enzymes 206 
PLA2 enzymes were found to be present in relatively high abundance and were represented 207 
overall by 17 and 19 proteins in N. naja and B. caeruleus venoms, respectively (Figs. 5 and 6). The 208 
members of this family induce a wide range of pharmacological effects including myotoxicity, 209 
neurotoxicity, hypotension, haemolysis, cardiotoxicity, antibacterial, coagulopathy, hemorrhage, edema, 210 
tissue damage and convulsion (Kini, 2003).  Neurotoxic PLA2 enzymes are among the most lethal toxic 211 
components in cobra and krait venoms (Tan et al., 1989; Yanoshita et al., 2006). Peptides belonging to a 212 
previously reported acidic PLA2 and a group I PLA2 were detected in both N. naja and B. caeruleus 213 
venoms (Tables S1 and S2). In the N. naja venom, peptides with sequences similar to several PLA2 214 
enzymes from the elapid species N. sagittifera, N. atra, N. kaouthia, N. melanoleuca and Micropechis 215 
ikaheka as well as some viperid species were detected (Table S1).  In the B. caeruleus venom, peptides 216 
similar to several PLA2 isoforms originally described from the elapid snakes B. multicinctus, B. fasciatus, 217 
B. candidus, N. naja, N. sagittifera, Brachyurophis roperi, Laticauda colubrina, Pseudechis australis, and 218 
Cacophis squamulous were detected (Table S2).  219 
3.4.2. 3FTxs 220 
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We identified 24 proteins in the N. naja venom belonging to the 3FTx family and 14 in the B. 221 
caeruleus venom (Figs. 5 and 6). The 3FTxs have a distinctive structural arrangement composed of three 222 
β-stranded loops that protrude from a small hydrophobic globular core that makes them appear like a 223 
hand with three extending fingers. This protein scaffold is stabilized by four conserved disulfide bonds 224 
located in the globular core (Kini and Doley, 2010). Despite having similarities in structure, they are 225 
known to exert diverse activities such as neurotoxicity, cardiotoxicity, cytotoxicity, and anti-platelet 226 
effects (Kini and Doley, 2010). The 3FTxs detected in the N. naja and B. caeruleus venoms belong to the 227 
short-chain neurotoxin, long-chain neurotoxin, ĸ-neurotoxin, muscarinic toxin and orphan subfamilies 228 
(Tables S1 and S2). In both venoms, peptides identical to those from N. naja cytotoxin 7, long neurotoxin 229 
1, and long neurotoxin 4; N. oxiana short neurotoxin 1; and N. nivea or N. kaouthia cytotoxin 2 were 230 
detected. (Tables S1 and S2). In N. naja venom, 3FTx peptides were obtained similar to sequences from 231 
the elapids N. naja, N. kaouthia, N. mossambica, N. atra, N. nivea, N. annulifera, N. oxiana and N. 232 
annulata annulata (Table S1). In the B. caeruleus venom, peptides similar to 3FTxs from the elapids B. 233 
candidus, B. multicinctus, N. kaouthia, N. naja, N. melanoleuca, and N. atra were identified (Table S2). 234 
3.4.3. SVMPs 235 
Analysis of the peptides obtained in our study revealed 13 SVMPs in the N. naja venom and five 236 
in the B. caeruleus venom (Figs. 5 and 6). SVMPs are organized into three broad classes- PI, PII (with 237 
subclasses a through e), and PIII (with subclasses a through d) based on differences in structure (Fox and 238 
Serrano, 2005, 2009, 2010). In addition to hemorrhagic activity, members of the SVMP family may also 239 
have fibrin(ogen)olytic activity, inhibit platelet aggregation, or be pro-inflammatory (Markland and 240 
Swenson, 2013). There is generally very little metalloproteinase content in elapid venoms (Li et al., 2004; 241 
Markland and Swenson, 2013) compared to viperids (Francischetti et al., 2004; Serrano et al., 2005; 242 
Cidade et al., 2006; Sanz et al., 2006). The SVMPs identified mostly belonged to the PIIIa subfamily, and 243 
peptides from zinc metalloproteinase disintegrins and other domains of SVMPs were found in both 244 
venoms (Tables S1 and S2). In N. naja venom, SVMP peptides showed similarity to sequences originally 245 
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from the elapids N. kaouthia, N. atra, B. multicinctus, Hoplocephalus bungaroides, Micrurus fulvius and 246 
Drysdalia coronoides as well as the viperid Echis carinatus sochureki (Table S1). SVMP peptides from 247 
B. caeruleus venom had similar sequences to those from the elapids B. multicinctus, N. kaouthia, and 248 
Micrurus fulvius (Table S2). 249 
3.4.4. CRISPs/helveprins 250 
A total of six CRISPs were identified in N. naja venom as compared to two in B. caeruleus 251 
venom, although they were the second largest group of non-enzymatic proteins found in both venoms 252 
(Figs. 5 and 6). The members of the CRISP family inhibit cyclic nucleotide-gated ion channels in 253 
photoreceptor and olfactory cells (Brown et al., 1999) and potassium activated smooth muscle contraction 254 
(Osipov et al., 2005; Ito et al., 2007). CRISP peptide sequences in the N. naja venom were similar to 255 
sequences from the elapids N. atra and N. kaouthia and from the viperids Trimesurus gracilis and D. 256 
russelii (Table S1). In the B. caeruleus venom, peptides with similar sequences to CRISPs originally 257 
identified from elapid B. candidus and Ophiophagus hannah were detected (Table S2).  258 
3.4.5. LAAOs 259 
A comparison of the number of LAAOs detected in both the venoms revealed six in the N. naja 260 
venom and two in the B. caeruleus venom (Figs. 5 and 6). LAAOs are homodimeric, high molecular 261 
weight enzymatic proteins (Tan and Fung, 2010) responsible for oxidizing hydrophobic L-amino acids 262 
thereby releasing α-keto acids, ammonia and H2O2 (Du and Clemetson, 2002; Dineshkumar and 263 
Muthuvelan, 2011). The product of this reaction, H2O2, causes edema formation; ADP or collagen-264 
induced platelet aggregation inhibition or activation; apoptosis; and antibacterial, antiparasitic, 265 
anticoagulant, hemolytic and hemorrhagic effects (Suhr and Kim, 1996). LAAO peptides in the N. naja 266 
venom were similar to peptide sequences of proteins from the elapids N. atra, Notechis scutatus, and 267 
Oxyuranus scutellatus as well as the viper D. russelii (Table S1). In the B. caeruleus venom, LAAO 268 
peptides were similar to those from the elapid B. multicinctus (Table S2). 269 
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3.4.6. 5’-Nuclotidases (5’-NTDs) 270 
There were two 5’-NTDs detected in the N. naja venom compared to one in the B. caeruleus 271 
venom (Figs. 5 and 6). Ubiquitous enzymes, 5’-NTDs are primarily responsible for causing disruption of 272 
physiological homeostasis in humans by inducing anticoagulant effects and by inhibiting platelet 273 
aggregation (Dhananjaya et al., 2006). They also act synergistically with other toxins to exert a more 274 
pronounced anti-coagulant effect during envenomation (Dhananjaya and D’Souza, 2010). Peptides of 5’-275 
NTDs from N. naja and B. caeruleus venoms showed sequence similarity to 5’-NTD sequences from 276 
Micrurus fulvius (Table S1) and Ovophis okinavensis (Table S2), respectively.  277 
3.4.7. Toxins specific to N. naja venom 278 
There were four proteins belonging to the CVF family detected in the N. naja venom (Fig. 5). 279 
CVF is a complement-activating protein present in cobra venom. It is a three-chain protein that 280 
functionally resembles C3b, the activated form of complement component C3 (Vogel et al., 2004). 281 
Peptides from this protein family showed similarity to CVF sequences from N. kaouthia (Table S1).  282 
Peptides belonging to two proteins of the poorly characterized toxin family of aminopeptidases 283 
were also found only in N. naja venom (Fig. 5). Aminopeptidases are exo-metalloproteases, and in 284 
mammals they are involved in normal physiological functions such as maintenance of blood pressure 285 
(Vajyapuri et al., 2010). Aminopeptidase peptides identified from N. naja venom showed similar 286 
sequence to those from the elapid Micrurus fulvius and the viperid Crotalus horridus (Table S1).  287 
Two proteins belonging to the PDE family were identified in N. naja venom (Fig. 5). The 288 
findings correlate with the earlier reports that claim low levels of PDEs in elapid venoms and none in 289 
Bungarus sp. (Aird, 2002). The members of the PDE family are responsible for the successive release of 290 
5’-mononucleotides from the 3’ end of polynucleotides (Iwanaga and Suzuki, 1979) and for supplying 291 
nucleotide substrates for the activity of other toxins, such as 5-NTDs (Aird, 2002; Valério et al., 2003). 292 
PDEs are also reported to inhibit platelet aggregation and lower mean arterial pressure (Russell et al., 293 
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1963). The detected PDE peptides showed similarity to sequences from the elapid Micrurus fulvius and 294 
the viperid Macrovipera lebetina (Table S1).  295 
Two ohanin/vespryn proteins were identified in N. naja venom (Fig. 5). Ohanin identified from 296 
O. hannah venom was the first snake venom protein shown to induce hypolocomotion and hyperalgesia 297 
in experimental mice (Pung et al., 2005). The peptides identified from N. naja venom showed similarity 298 
to the isoforms from N. kaouthia and O. hannah (Table S1).  299 
Only one SVSP was identified from the N. naja venom (Fig. 5). These proteins are widely 300 
distributed in viperid venoms but are found quite rarely in elapid venoms (Jin et al., 2007). SVSPs show 301 
fibrin(ogen)olytic activities and are not susceptible to hirudin, heparin, or other serine protease inhibitors, 302 
so they result in abnormal fibrin clots (Matsui et al., 2000). The identified sequences showed similarity to 303 
SVSPs from N. atra (Table S1). 304 
The analysis also revealed peptides belonging to one previously reported VNGF protein from N. 305 
naja venom (Table S1). VNGFs isolated from the elapids have properties similar to those of nerve growth 306 
factor isolated from mouse submaxillary glands and are responsible for the survival and differentiation of 307 
neurons (Angeletti, 1970; Barbacid, 1995).  308 
One previously reported isoform of Kunitz-type serine protease inhibitor (KPI) was identified in 309 
N. naja venom (Table S1). Several KPIs have been purified and characterized from elapid and viperid 310 
snake venoms (Shafqat et al., 1990). A wide variety of biological functions such as inhibition of serine 311 
proteases, blocking of ion channels, interference in blood coagulation, inflammation and fibrinolysis are 312 
exhibited by KPIs (Mukherjee et al., 2014).   313 
3.4.8. Toxins specific to B.caeruleus venom  314 
In B. caeruleus venom, peptides were detected for two hyaluronidase isoforms (Fig. 6). The 315 
members of this protein family cause degradation of hyaluronic acid in the extracellular matrix which is 316 
important in the diffusion of toxins from the site of a bite into the circulation. Hence, they are also called 317 
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“spreading factors” (Kemparaju and Girish, 2006). Hyaluronidases generate a wide range of metabolic 318 
products through hyaluronic acid degradation (Kemparaju and Girish, 2006). Hyaluronidase peptides in 319 
the B. caeruleus venom showed similarity to those from the viper Bitis arietans (Table S2).  320 
One AChE was detected in the B.caeruleus venom (Fig. 6). These proteins play a crucial role in 321 
cholinergic transmission and have been reported to occur at high levels in the venoms of elapid snakes, 322 
particularly in Bungarus (Frobert et al., 1997). Identified peptides for this protein showed sequence 323 
similarity to AChEs from B. fasciatus (Table S2). 324 
In-depth analyses of identified proteins in N. naja and B. caeruleus venoms indicated that both 325 
are rich in PLA2s and 3FTxs.  This correlates well with the severe neurotoxicity and cytotoxicity observed 326 
in N. naja and B. caeruleus envenomations (Law et al., 2014). The other protein families, with relatively 327 
low abundance, seem to have minor physiological effects on envenomated humans. 328 
3.5. Peptide coverage analysis  329 
The prediction of K/R rich or poor regions and potential glycosylation sites in proteins is critical for 330 
a complete proteomic profiling, as it helps predict coverage to be expected based on any given technique. 331 
Our in-house MS visualization program generated figures that show the overlapping of individual tryptic 332 
peptides and the overall coverage in the identified proteins. Here, we have shown coverage data for toxins 333 
from the PLA2, 3FTx, CRISP, and SVMP families in both N. naja and B. caeruleus venom (Figures 7 and 334 
8). Similarly, figures were generated for other toxin families (data not shown). The coverage and amount of 335 
overlap of tryptic peptides were higher for PLA2s and 3FTxs than for CRISPs and SVMPs in both N. naja 336 
and B. caeruleus possibly due to a number of factors such as smaller sizes of 3FTxs and PLA2s, tryptic 337 
cleavage patterns (numbers and locations of K/R residues), and relative concentrations of each toxin in the 338 
venom.  In the N. naja venom potential glycosylation sites were observed in proteins belonging to the 3FTx, 339 
CRISP, PLA2 and SVMP families, although only 3FTx and SVMP proteins in B. caeruleus venom showed 340 
the same possibilities.  341 
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4. Conclusion 342 
Analysis of the proteomes of N. naja and B. caeruleus venoms using the complementary 343 
approaches of gel electrophoresis, liquid chromatography and mass spectrometry has generated an in-344 
depth characterization of these venoms. We have identified 81 protein species from N. naja venom (a 345 
much greater number than previously reported in proteomic studies) and 46 from B. caeruleus venom. 346 
The detection of such a large number of venom proteins, including PLA2s, 3FTxs and SVMPs, correlate 347 
well with clinical reactions reported in the literature. Hence, it can be concluded that using the three 348 
complementary strategies, rather than one can yield comparatively more information and give a better 349 
overall characterization of venom proteomes.  350 
In this study we noted the presence of AChEs, PDEs, 5’-NTDs, and SVSPs specifically in N. naja 351 
venom as well as hyaluronidases and AChEs solely in B. caeruleus venom. This analysis clearly shows 352 
the differences in the toxin composition between the venoms and contributes further to the current 353 
knowledge of venom proteins in these species. To determine such variations in venom composition, 354 
analysis of samples from specific localities needs to be done, and that will help in designing more 355 
efficacious, region-specific anti-venoms. 356 
The range of molecular sizes of proteins and peptides is a major obstacle in proteomic analysis of 357 
snake venoms. With the extensive developments in proteomic techniques, it has become possible to better 358 
elucidate the complete toxin profiles of snake venoms. As such, we have utilized complementary 359 
techniques to create an expanded understanding of the proteomes of the venoms of these two medically-360 
important species.  361 
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Fig.1. SDS-PAGE profiles of the crude venoms of Naja naja and Bungarus caeruleus. Lanes: 1, standard protein ladder; 593 
2, N. naja crude venom; and 3, B. caeruleus crude venom. Abbreviations: 3FTxs, three finger toxins; CRISPs, cysteine-594 
rich secretory proteins (helveprins); CVFs, cobra venom factors; KPIs, Kunitz-type serine protease inhibitors;  LAAOs, L-595 
amino acid oxidases; PLA2s, phospholipases A2; PDEs, phosphodiesterases; SVMPs, snake venom metalloproteinases; 596 
and VNGFs, venom nerve growth factors  597 
 598 
Fig.2. Gel filtration chromatography profile of crude Naja naja venom. Crude venom (100 mg in 2.5 ml of 50 mM 599 
Tris-HCl, pH 7.4) was loaded onto a Superdex 200 column pre-equilibrated with the same buffer. Proteins were 600 
eluted with the same buffer at a flow rate of 1 ml/min and monitored at 215 nm. Insets indicate the snake venom 601 
protein families identified by tandem mass spectrometry in individual peaks. Numbers in parenthesis are the number 602 
of protein species identified for each family. Abbreviations: 3FTxs, three finger toxins; 5’-NTDs, 5’-nucleotidases; 603 
CRISPs, cysteine-rich secretory proteins (helveprins); CVFs, cobra venom factors; KPIs, Kunitz-type serine 604 
protease inhibitors; LAAOs, L-amino acid oxidases; PLA2s, phospholipases A2; PDEs, phosphodiesterases; SVMPs, 605 
snake venom metalloproteinases; and VNGFs, venom nerve growth factors. 606 
 607 
Fig.3. Gel filtration chromatography profile of crude Bungarus caeruleus venom. Crude venom (100 mg in 2.5 ml of 608 
50 mM Tris-HCl, pH 7.4) was loaded onto a Superdex 200 column pre-equilibrated with 50 mM Tris-HCl (pH 7.4). 609 
Proteins were eluted with the same buffer at a flow rate of 1 ml/min and monitored at 215 nm. Insets indicate the 610 
snake venom protein families identified by tandem mass spectrometry in individual peaks. Numbers in parenthesis 611 
are the number of protein species identified for each family. Abbreviations: AChEs, acetylcholinesterases; 3FTxs, 612 
three finger toxins; 5’-NTDs, 5’-nucleotidases; CRISPs, cysteine rich secretory proteins (helveprins); LAAOs, L-613 
amino acid oxidases; PLA2s, phospholipases A2; and SVMPs, snake venom metalloproteinases. 614 
 615 
Fig.4. Venn diagrams of the number of protein species obtained from A) Naja naja and B) Bungarus caeruleus 616 
venoms using three proteomic approaches.  Differently shaded areas indicate overlap among the various techniques. 617 
 618 
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Fig.5. Relative abundance of venom protein families identified by ESI-LCMS/MS of crude Naja naja venom. Each 619 
section represents the number of protein species found within that specific toxin protein family, with relative 620 
percentage in parentheses. Abbreviations: 3FTxs, three finger toxins; 5’-NTDs, 5’-nucleotidases; CRISPs, cysteine-621 
rich secretory proteins (helveprins); CVFs, cobra venom factors; KPIs, Kunitz-type serine protease inhibitors; 622 
LAAOs, L-amino acid oxidases; PLA2s, phospholipases A2; PDEs, phosphodiesterases; SVMPs, snake venom 623 
metalloproteinases; and VNGFs, venom nerve growth factors. 624 
 625 
Fig.6. Relative abundance of venom protein families identified by ESI-LCMS/MS of Bungarus caeruleus crude 626 
venom. Each section represents the number of protein species found within that specific toxin protein family, with 627 
relative percentage in parentheses. Abbreviations: AChEs, acetylcholinesterases; 3FTxs, three finger toxins; 5’-NTDs, 628 
5’-nucleotidases; CRISPs, cysteine rich secretory proteins (helveprins); LAAOs, L-amino acid oxidases; PLA2s, 629 
phospholipases A2; and SVMPs, snake venom metalloproteinases. 630 
Fig.7. Sequence coverage of the major protein families in Naja naja venom. Alphanumeric designations  on the left of 631 
each panel represent NCBI accession numbers. Panels: (A) 3FTxs, three-finger toxins; (B) PLA2s, phospholipases A2; 632 
(C) CRISPs, cysteine-rich secretory proteins (helveprins); and (D) SVMPs, snake venom metalloproteinases. Blue, 633 
black  and brown regions show the lysine and arginine poor, medium and rich regions, respectively. Red, purple and 634 
green bars indicate tryptic peptides of low, medium and high score, respectively, based on SEQUEST analysis of the 635 
corresponding proteins. In addition, cyan regions in the protein sequence represent potential glycosylation sites. 636 
 637 
Fig.8. Sequence coverage of the major protein families in Bungarus caeruleus venom. Alphanumeric designations 638 
on the left of each panel represent NCBI accession numbers. Panels: (A) 3FTxs, three-finger toxins; (B) PLA2s, 639 
phospholipases A2; (C) CRISPs, cysteine-rich secretory proteins (helveprins); and (D) SVMPs, snake venom 640 
metalloproteinases. Blue, black and brown regions show the lysine and arginine poor, medium and rich regions, 641 
respectively. Red, purple and green bars indicate tryptic peptides of low, medium and high score, respectively, based 642 
on SEQUEST analysis of the corresponding proteins. In addition, cyan regions in the protein sequence represent 643 
possible glycosylation sites. 644 
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